FDA Inspection
Teva Canada LimitedTeva Canada Limited – FDA Inspection, Nov 18, 2016
Record Details
This FDA Inspection record concerns Teva Canada Limited, with an inspection on November 18, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · ed67cbd2-8da4-4f22-9bb4-47e50da685b3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 992270
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Teva Canada Limited
5| Date | Classification | Office | Project area |
|---|---|---|---|
| April 24, 2025 | VAI | Office of Inspections and Investigations | Drug Quality Assurance |
| April 26, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 21, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 29, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 29, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Teva Canada Limited
- FDA Inspection 1265556 - 2025-04-24
- FDA Inspection 1092488 - 2019-04-26
- FDA Inspection 868166 - 2014-02-21
- FDA Inspection 750624 - 2011-09-29
- FDA Inspection 680578 - 2010-07-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.